THE VIRTUAL CELL

When AI Begins to Simulate Life

How a $1.8 billion collaboration is building the data foundation for predictive models of cells - and what that could mean for drug discovery, CRISPR, aging, regeneration and personalized medicine.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

THE SHORT VERSION

AI is moving from reading pieces of biology toward predicting how living systems behave. The Virtual Biology Initiative is trying to create the enormous, standardized experimental datasets needed to train those models. The goal is not to replace laboratories, but to make experiments more intelligent before they ever reach the bench.

CURRENT SNAPSHOT · 14 OCTOBER 2026

Written for curious non-specialists. Company announcements, independent reporting and research examples are clearly distinguished. “Virtual cell” is treated as an emerging predictive-modeling goal, not a finished digital organism.

WHY THIS MATTERS

The internet taught AI language. Biology has no internet.

For most of the modern AI era, the raw material was already waiting for us. Language models had books, websites, code, encyclopedias and decades of human writing. Image models had vast collections of pictures. The internet had accidentally become a gigantic training set.

Biology is different. If scientists want to know how a human liver cell responds to a drug, what happens after a particular gene is switched off, or how an immune cell behaves around a tumor, the answer usually has to be created experimentally. Someone must grow the cells, perturb the biology, measure what changes and record the result.

That is why one of the most important new AI-biology efforts is not primarily about building a larger chatbot. It is about building enough reliable biological data to teach AI how cells behave. On 7 October 2026, Biohub announced a major expansion of its Virtual Biology Initiative with the U.S. Department of Energy, the National Institutes of Health, Google DeepMind, Isomorphic Labs, Meta and other research partners. Together, the organizations described a combined $1.8 billion commitment in funding, data, computation and measurement technology.[1]

THE AMBITION

Build AI models that can predict what a living cell is likely to do before scientists perform the experiment in the physical world.

FROM STATIC PARTS TO DYNAMIC SYSTEMS

What exactly is a virtual cell?

A cell is not a bag containing DNA. It is a constantly changing system. Genes become active or quiet. RNA messages are produced and destroyed. Proteins interact. Molecules enter and leave. Hormones and immune signals arrive. Mitochondria produce energy. Cells communicate with their neighbors. Damage occurs, and repair systems respond.

Current AI can already solve pieces of this puzzle. AlphaFold transformed protein-structure prediction. Other systems analyze genomes, gene expression, microscopy, single-cell measurements and molecular interactions. But predicting one component is very different from predicting the behavior of the whole system.

The virtual-cell goal is therefore not a pretty 3D animation of a cell. It is a predictive model: give the system a biological situation, change something, and estimate what the cell may do next. Biohub describes this as enabling researchers to ask and answer biological questions digitally before validating them experimentally.[1]

SIMPLE MENTAL MODEL

Normal experiment: change something in a real cell → wait → measure what happened. Virtual-cell workflow: describe the change → model predicts likely outcomes → perform the most informative real experiments.

WHY AI CANNOT JUST “FIGURE BIOLOGY OUT”

The real bottleneck is data

This is the less glamorous part of the story, and possibly the most important. AI models learn from examples. A language model can encounter countless examples of language because humans already wrote them. A biological model needs examples of how different cell types respond to drugs, genetic edits, disease, inflammation, stress, neighboring cells and changing environments.

Those examples do not exist in one clean public archive. They have to be manufactured through wet-lab science using microscopes, sequencers, perturbation tools, imaging systems and increasingly automated laboratories.

Reuters reported that existing datasets may contain measurements from hundreds of millions of cells, while truly powerful predictive systems could eventually require billions or even trillions of cellular measurements. Biohub aims to produce standardized, multimodal datasets across many cell types and conditions so future models have something trustworthy to learn from.[3][4]

A USEFUL SHIFT

In language AI, the internet supplied the data. In biology, the next generation of AI may depend on building scientific data factories on purpose.

Inside the $1.8 billion collaboration

The headline figure is a combination of money, existing data assets, computation and new measurement technologies. It is not a single $1.8 billion cheque to one laboratory.[1][2]

AI AS RESEARCH PARTNER

Why DeepMind is involved

For Google DeepMind, this fits a broader shift toward AI for science. The company has worked on protein structure, genomics, scientific reasoning, materials and other domains where the challenge is not simply generating text, but helping researchers search huge spaces of possibilities.

In May 2026, DeepMind introduced Co-Scientist, a Gemini-based multi-agent research system designed to generate, debate and refine scientific hypotheses. In one aging-research collaboration, the system scanned large literatures and screening results, proposed more than twenty plausible genetic factors to test, and helped researchers narrow the search. DeepMind reported that some proposed factors were then validated experimentally as pushing cells toward more youthful states.[5][6]

That distinction matters: the AI did not prove the biology. It proposed candidates. The laboratory remained the judge. But combining hypothesis-generating AI with predictive cell models and increasingly automated experiments points toward a new research workflow.

FROM HYPOTHESIS TO FEEDBACK

The emerging scientific loop

Traditional research often looks like this: read papers, form a hypothesis, design an experiment, run it, analyze the results, then repeat.

The emerging AI-assisted version may become more tightly connected: AI reads literature, proposes hypotheses, predictive models estimate likely outcomes, automated laboratories run selected experiments, new data returns to the model, and the next experiment is chosen with better information.

This is sometimes described as a closed-loop or self-driving laboratory. Humans still decide which questions matter, what evidence counts, whether results are artifacts, what risks are acceptable and when an idea is ready for animal or human testing. AI may compress the search space. It does not abolish reality.

What could a virtual cell actually be used for?

Drug discovery

A predictive model could help rank molecules earlier: which compounds are most likely to affect the desired pathway, which may be toxic, and which cell types may respond differently. It would not prove a drug is safe or effective; physical experiments and clinical trials would still be required.

CRISPR and gene editing

Before making a real edit, researchers could ask what downstream pathways may change, whether cell identity might be disturbed, and which unintended effects deserve attention first.

Cancer

Tumors contain populations of cells that evolve, communicate and respond differently to therapy. Better cell models could help researchers explore why one tumor responds while another becomes resistant.

Aging and epigenetics

Aging research often measures many interacting changes at once. Predictive models may eventually connect gene regulation, RNA, proteins, metabolism and cell state, helping distinguish genuine functional rejuvenation from a biomarker that merely looks younger.

Personalized medicine

The long-term ambition is not merely a generic virtual cell but models that incorporate a person’s genome, disease state, cell type and treatment context. That remains well beyond today’s capabilities, but it explains the medical importance of predictive biology.

REALITY CHECK

What this project is not

Scientists have not built a perfect computational duplicate of a living human cell. They cannot yet enter “skin cell, age 67, apply treatment X” and receive a guaranteed answer.

Biology contains huge numbers of interacting variables, many of which are incompletely measured. Models can be confidently wrong. Correlation can masquerade as mechanism. Rare events can be missed. A cell in a living body also behaves differently from an isolated cell because hormones, nerves, immune cells, blood flow and neighboring tissues all influence it.

For now, “virtual cell” is best understood as an increasingly ambitious predictive-modeling program, not a finished digital organism.

THE RIGHT STANDARD

A useful virtual cell does not need to be an oracle. It needs to make testable predictions that help scientists choose better experiments.

WHO GETS TO LEARN FROM LIFE?

The open-science question

Biohub says the initiative is intended to create an open, standardized biological-data resource for the wider research community. Publicly funded work is not meant to carry the same commercial exclusivity as privately funded data, while reporting indicates that industry funders may receive a temporary period of early access before some data are released more broadly.[1][3]

That tension will matter. If these datasets become foundational to future medicine, who gets early access? Can small laboratories compete with companies that possess enormous compute? Which datasets remain open, and which become strategically valuable assets?

The initiative is explicitly trying to build shared infrastructure rather than one proprietary virtual-cell monopoly. But in predictive biology, high-quality experimental data may become as strategically important as computing power.

THE INFRASTRUCTURE MAY MATTER MORE THAN THE FIRST MODEL

Biology’s ImageNet moment?

Computer vision improved dramatically once researchers had standardized image datasets on which models could train and compete. Language AI benefited from large text corpora. Protein AI benefited from decades of experimentally determined protein structures.

Biology may now be trying to create an equivalent foundation at the cellular level: deliberately manufacture the data needed to unlock the next generation of models. Biohub’s expansion announcement makes this logic explicit - better predictive models require much more open experimental data showing how cells behave and respond to change.[1]

If that infrastructure works, its importance may outlast any single model. Once standardized laboratories continuously produce AI-ready biological measurements, those datasets could support scientific systems nobody has designed yet.

THE BIGGER SHIFT

From reading biology to predicting biology

For most of modern biology, humans have learned by observing living systems. We sequence DNA, measure proteins, look through microscopes, perturb genes, test drugs and then try to explain what happened.

AI introduces a new possibility: can biology become predictive enough that we can model what happens next?

Predictive biology will not remove experiments, animal studies or clinical trials. But it could make the search much more intelligent. Instead of testing thousands of possibilities blindly, researchers could prioritize the experiments most likely to teach us something useful. Instead of discovering an unexpected gene-editing effect only after the fact, a model might warn researchers which pathways deserve attention. Instead of studying aging one pathway at a time, scientists may be able to model larger interacting systems.

The destination is not a biological oracle. It is something more useful: a scientific tool capable of being wrong in ways we can test.

BUNCOSMOS TAKEAWAY

The internet gave AI the data to learn our language. Scientists are now trying to build the data that will let AI learn the language of cells.

The bigger story

AI entered biology by helping us read life: protein structures, genomes, microscopy and medical data.

It is increasingly helping scientists design biology: molecules, proteins, gene editors and experiments.

The Virtual Biology Initiative points toward another step - models that can predict biological systems well enough to guide what scientists test next.

That would not mean biology is solved. It would mean biology is becoming increasingly computable. And for questions ranging from cancer and genetic disease to aging and regeneration, that could change the speed at which ideas become experiments and experiments become medicine.

If the effort succeeds, the most important AI model of the next decade may not be the one that talks most convincingly like a human. It may be the one that can tell us, with increasing accuracy, what a human cell is likely to do next.

References & further reading

Primary institutional sources are listed first, followed by independent reporting. All links checked 14 October 2026.

[1] Biohub. “International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease.” 7 October 2026. Source

[2] Biohub. “Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology.” 29 April 2026. Source

[3] Reuters. “US government, Google join Zuckerberg-backed Biohub in $1.8 billion push for AI biology data.” 7 October 2026. Source

[4] Reuters. “AI wants to cure disease. It needs data first.” 7 October 2026. Source

[5] Google DeepMind. “Co-Scientist: A multi-agent AI partner to accelerate research.” 19 May 2026. Source

[6] Google DeepMind. “Fast-tracking genetic leads to reverse cellular aging.” 19 May 2026. Source

EDITORIAL NOTE

This article distinguishes project goals from demonstrated capability. “Virtual cell” refers to an emerging class of predictive biological models. Predictions remain hypotheses until experimental and clinical evidence confirms them.